Interleukin Genetics Establishes Partnership with Greater Philadelphia Business Coalition on Health
Mar 02, 2017 13:01 pm UTC| Business
WALTHAM, Mass., March 02, 2017 -- Interleukin Genetics, Inc. (OTCQB:ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today that it has entered into a partnership with the Greater...
Mar 02, 2017 13:01 pm UTC| Business
DUBLIN, Ireland, March 02, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and...
Mar 02, 2017 13:01 pm UTC| Business
DUBLIN, Ireland, March 02, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and...
Mar 02, 2017 13:01 pm UTC| Business
NEW HAVEN, Conn. and FLORENCE, Italy, March 02, 2017 -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, and Menarini Group, an Italian...
Mar 02, 2017 13:01 pm UTC| Business
NEW HAVEN, Conn. and FLORENCE, Italy, March 02, 2017 -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, and Menarini Group, an Italian...
Mar 02, 2017 13:00 pm UTC| Business
PARIS, March 02, 2017 -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat diseases of ageing, announces today the complete results of the SARA-PK...
Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference
Mar 02, 2017 13:00 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, March 02, 2017 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that James Noble, Adaptimmune’s Chief Executive Officer,...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood